Complement activation induces excessive T cell cytotoxicity in severe COVID-19

Cited by (222)

Items 101–200 of 222

1. Pro-inflammatory NK-like T cells are expanded in the blood and inflamed intestine in Crohn’s disease
   Cristina Maria Chiarolla, Axel Ronald Schulz, Michael Meir, Sebastian Ferrara, Yin Xiao, Simone Reu‐Hofer, Addi J. Romero‐Olmedo, Valeria Falcone, Katja Hoffmann, Maike J. Büttner-Herold et al. · 2024 · Mucosal Immunology
2. Role for Complement C5 in Eosinophilic Inflammation of Severe Asthma
   Cong Dong, Shaohua Lu, Zhenan Deng, Xuliang Cai, Huahao Shen, Guochao Shi, Changxing Ou, Zuofu Peng, Wei Jiang, Xiuhua Fu et al. · 2025 · Allergy
3. Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
   Hong‐Yi Zheng, 中国科学院昆明动物研究所遗传资源与进化国家重点实验室, 生物安全大科学中心, 中国科学院昆明动物研究所-香港中文大学生物资源与疾病分子机理联合实验室, 云南 昆明 650223, 中国, Tian‐Zhang Song, Yong‐Tang Zheng, 中国科学院昆明动物研究所模式动物表型与遗传研究国家重大科技基础设施(灵长类设施), 国家非人灵长类实验动物资源库, 云南 昆明 650107, 中国 · 2024 · 动物学研究
4. Immune signature of patients with cardiovascular disease predicts increased risk for a severe course of COVID‐19
   Manina Günter, Karin Anne Lydia Mueller, Mathew J. Salazar, Sarah Gekeler, Carolin Prang, Tobias Harm, Meinrad Gawaz, Stella E. Autenrieth · 2024 · European Journal of Immunology
5. Neural network-assisted humanisation of COVID-19 hamster transcriptomic data reveals matching severity states in human disease
   Vincent D. Friedrich, Peter Pennitz, Emanuel Wyler, Julia Maria Adler, Dylan Postmus, Kristina Müller, Luiz Gustavo Teixeira Alves, Julia Prigann, Fabian Pott, Daria Vladimirova et al. · 2024 · EBioMedicine
6. Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense
   Rui Qin, Chenyi An, Wei Chen · 2022 · Journal of Molecular Biology
7. Angiotensin-(1–7) alleviates acute lung injury by activating the Mas receptor in neutrophil
   Liming Wang, Tian Jiang, Yilin Yang, Junjie Mao, Qiong Wang, Ronghuan Yu, Baoqing Wang, Jun Yin · 2022 · Annals of Translational Medicine
8. Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells
   Kelsey E. Lesteberg, Paula Araya, Katherine A. Waugh, Lakshmi Chauhan, Joaquin Maximiliano Espinosa, John David Beckham · 2023 · Frontiers in Immunology
9. Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
   Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica Di Cristanziano, Kirsten Alexandra Eberhardt, Paula Stubbemann, David Hillus, Pinkus Tober‐Lau, Parnika Mukherjee, Friederike Münn et al. · 2023 · JCI Insight
10. Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events
    Leonie Müller‐Jensen, Nora Möhn, Thomas Skripuletz, Sophia Carl, J. Meirion Thomas, Lea Martha Grote-Levi, Sandra Nay, Philipp Ivanyi, Imke von Wasielewski, Ralf Gutzmer et al. · 2025 · Journal of Neurology
11. Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents
    Xiujuan Zhao, Ruikun Du, Lijun Rong · 2025 · Pathogens
12. Epigenetics of SARS-CoV2 (COVID-19)
    Sarita Rawat, Ritu Mehra Gilhotra, Santosh Kumar Singh, Asif Ahmad Bhat, Abhijeet Ojha, Karuna Dhaundhiyal, Ishwar Singh Dhramshaktu, Gaurav Gupta · 2023 · Springer eBooks
13. Complement is primarily activated in the lung in a mouse model of severe COVID-19
    Peter J. Szachowicz, Christine Wohlford-Lenane, Cobey J. H. Donelson, Shreya Ghimire, Andrew L. Thurman, Biyun Xue, Timothy J. Boly, Abhishek Verma, Leila MašinoviĆ, Jennifer Bermick et al. · 2025 · iScience
14. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
    Márton Kolossváry, Christopher R. deFilippi, Sara McCallum, Kathleen V. Fitch, Marissa R Diggs, Evelynne S. Fulda, Heather Jane Ribaudo, Carl J. Fichtenbaum, Judith A. Aberg, Carlos Malvestutto et al. · 2023 · EBioMedicine
15. Alterations in the CD56− and CD56+ T Cell Subsets during COVID-19
    Julia D. Vavilova, Maria O. Ustiuzhanina, Anna A. Boyko, Maria A. Streltsova, Sofya A. Kust, Leonid M. Kanevskiy, Rustam N. Iskhakov, Alexander M. Sapozhnikov, Ekaterina O. Gubernatorova, Marina S. Drutskaya et al. · 2023 · International Journal of Molecular Sciences
16. Enhancing the Treatment of Uncontrolled Inflammation through the Targeted Delivery of TPCA-1-Loaded Nanoparticles
    Zhaozhao Chen, Lu Tang, Lili Luo, Wenjing Luo, Yingying Li, Xindi Wang, Linlin Huang, Yu Hu, Heng Mei · 2023 · Pharmaceutics
17. Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients
    Tomonori Kaneko, Sally Ezra, Rober Abdo, Courtney Voss, Shanshan Zhong, Xuguang liu, Owen F.J. Hovey, Claudio M. Martin, Marat Slessarev, Logan R. Van Nynatten et al. · 2024 · Clinical Proteomics
18. The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease
    Agnes Carolin, David Michael Frazer, Kexin Yan, Cameron Bishop, Bing Tang, Wilson Nguyen, Sheridan L. Helman, Jay Christopher Horvat, Thibaut Larcher, Daniel J. Rawle et al. · 2024 · Frontiers in Microbiology
19. Integration of protein context improves protein-based COVID-19 patient stratification
    Jinlong Gao, Jiale He, Fangfei Zhang, Qi Xiao, Xue Cai, Xiao Yi, Siqi Zheng, Ying Zhang, Donglian Wang, Guangjun Zhu et al. · 2022 · Clinical Proteomics
20. Intestinal location- and age-specific variation of intraepithelial T lymphocytes and mucosal microbiota in pigs.
    J. Wiarda, Hannah R. Watkins, N. Gabler, Christopher L. Anderson, C. Loving · 2022 · Developmental and Comparative Immunology
21. Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition
    Mercedes García‐Gasalla, María Berman-Riu, Adrián Rodríguez, Amanda Iglesias, Pablo Arturo Fraile-Ribot, Núria Toledo-Pons, Elisabet Pol-Pol, Adrian Ferre Beltran, Francisca Artigues Serra, María Luisa Martín-Pena et al. · 2023 · Cytokine
22. Monocytes Subsets Altered Distribution and Dysregulated Plasma hsa-miR-21-5p and hsa- miR-155-5p in HCV-Linked Liver Cirrhosis Progression to Hepatocellular Carcinoma
    Reham Hammad, Mona Abd EL Rahman Eldosoky, Asmaa Abd Elsalam Elmadbouly, Reda Badr Aglan, Sherihan G. AbdelHamid, Samy Zaki, Elham Ali, Fatma Al Zahraa Abdel Hakem, Alshimaa M Mosaad, Neamat A. Abdelmageed et al. · 2023 · Research Square
23. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
    Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, Philipp Georg, David Hillus, Anna Luisa Hiller, Rosario Astaburuaga-García, Nils Blüthgen, Emanuel Wyler, Katrin Vogt et al. · 2025 · Cell Reports Medicine
24. Mapping NK cell diversity in response to COVID-19 and mRNA vaccination
    Yosuke Kishi, Yu-Chen Liu, Masakazu Ishikawa, Maika Yamashita, Hisatake Matsumoto, Hiroshi Ogura, Shuhei Sakakibara, Daisuke Okuzaki · 2025 · Scientific Reports
25. Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
    Martina Severa, Marilena Paola Etna, Emanuele Andreano, Daniela Ricci, Giada Cairo, Stefano Fiore, Andrea Canitano, Andrea Cara, Paola Stefanelli, Rino Rappuoli et al. · 2024 · iScience
26. Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections
    Tulika Singh, Andrew N. Macintyre, Thomas W. Burke, Jack G. Anderson, Elizabeth Petzold, Erica L. Stover, Matthew J. French, Thomas H. Oguin, Todd DeMarco, Micah T. McClain et al. · 2024 · Frontiers in Immunology
27. Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure
    Kezhen Yang, Jipeng Liu, Yu Gong, Yinyin Li, Qingguo Liu · 2022 · Frontiers in Immunology
28. Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation
    Anthony Joseph Leonardi, Christos Argyropoulos, Adam Hamdy, Rui B. Proenca · 2022 · Frontiers in Immunology
29. Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
    Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi, Michael Friedrich Osthoff · 2022 · Molecular Immunology
30. Similar Spatial Expression of Immune‐Related Proteins in SARS‐CoV‐2 Placentitis and Chronic Histiocytic Intervillositis
    Michelle Broekhuizen, Marie‐Louise van der Hoorn, Disha Vadgama, Michael Eikmans, Bojou J. Neecke, Johannes J. Duvekot, Pieter L. A. Fraaij, Irwin K. M. Reiss, Dana A. M. Mustafa, Lotte E. van der Meeren et al. · 2025 · European Journal of Immunology
31. Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels
    Xiaohan Liu, Zhihao Xu, Yilun Tong, Changtai Wang, Yueqi Yao, Yujie Diao, Jingyuan Ma, Shijun Zhou, Yi‐Nan Du, Zhenhua Zhang et al. · 2025 · Advanced Science
32. Single-cell RNA sequencing unravels chondrocyte heterogeneity and immune cell interactions in knee osteoarthritis pathogenesis
    Junru Li, Hong Wang, Shidian Xu, Yunzhi Liu, Zhenjie Wang · 2026 · Clinical Rheumatology
33. Predicting COVID-19 Severity Integrating RNA-Seq Data Using Machine Learning Techniques
    Javier Bajo-Morales, Daniel Castillo-Secilla, Luis Javier Herrera, Octavio Caba, Jose Carlos Prados, Ignacio Rojas · 2022 · Current Bioinformatics
34. Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia
    Dayna S. McManus, Matthew W. Davis, Alex Ortiz, C.J. Britto-Leon, Charles S. Dela Cruz, Jeffrey E. Topal · 2022 · Clinics in Chest Medicine
35. SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Charlie Fricke, Florian Pfaff, Lorenz Ulrich, Nico Joël Halwe, Jacob Schön, Laura Timm, Weda Hoffmann, Susanne Rauch, Benjamin Petsch, Donata Hoffmann et al. · 2023 · European Journal of Immunology
36. COVID-19 pathogenesis
    Asiya Kamber Zaidi, Rohan Bir Singh, Syed A. A. Rizvi, Puya Dehgani‐Mobaraki, Nicola Palladino · 2024 · Progress in molecular biology and translational science
37. Entwicklung und Fortschritte des Nationalen Obduktionsnetzwerks (NATON)
    Svenja Windeck, Kristina Allgoewer, Saskia Freifrau von Stillfried, Lucas Triefenbach, Ulrike Nienaber, Roman David Bülow, Rainer Röhrig, Benjamin Ondruschka, Peter Boor, NATON · 2024 · Die Pathologie
38. Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomes
    Santosh Dhakal, Anna Yin, Marta Escarra‐Senmarti, Zoe O Demko, Nora Pisanic, Trevor Scott Johnston, Maria Isabel Trejo‐Zambrano, Kate L. Kruczynski, John S. Lee, Justin P. Hardick et al. · 2024 · Communications Medicine
39. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2023 · eLife
40. Stimulation of PSTPIP1 to trigger proinflammatory responses in asymptomatic SARS-CoV-2 infections
    Ruili Ji, Yue Wu, Yuhua Ye, Yanling Li, Yizhe Li, Guojiu Zhong, Wentao Fan, Chengjuan Feng, Hui Chen, Xiangyun Teng et al. · 2024 · Heliyon
41. The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis
    Madison Stoddard, Lin Yuan, Sharanya Sarkar, Debra Van Egeren, Shruthi Mangalaganesh, Ryan P. Nolan, Michael S. Rogers, Greg Hather, Laura Forsberg White, Arijit Chakravarty · 2025 · Vaccines
42. Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection
    Xiaodi Yang, Ye Shen, Bo Tang, Jialin Zhu, Bingjie Wang, Qingyun Wang, Wenmin Tian, Stefan Wuchty, Ziding Zhang, Zeyin Liang et al. · 2025 · Molecular & Cellular Proteomics
43. The Complement System in the Setting of Critical Illness—A Narrative Review
    Kleio Ampelakiotou, Ioanna Nikitopoulou, Stelios Kokkoris, Αnastasia Kotanidou, Ioanna Dimopoulou, Maria G. Detsika · 2026 · Biomolecules
44. A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma
    Toyoshi Yanagihara, Masako Kadowaki, Junji Otsuka, Akiko Ishimatsu, Kazuhito Taguchi, Yuki Moriuchi, Hiroaki Ogata, Atushi Moriwaki, Makoto Yoshida · 2023 · Cureus
45. Pathology of COVID-19 Lung Disease
    Alain Borczuk · 2023 · Surgical pathology clinics
46. Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
    Eva Tranter, Marco Frentsch, Marie Luise Hütter‐Krönke, Giang Lam Vuong, David Busch, Lucie Loyal, Larissa Henze, Stanislav Rosnev, Igor‐Wolfgang Blau, Andreas Thiel et al. · 2024 · Journal of Medical Virology
47. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2024 · eLife
48. Decrease of Tregs cells and increase of exhausted Treg cells as the predictors of COVID19 severity
    Seyed Mehdi Mirniam, Alireza Andalib, Maedeh Radandish, Ramin Sami, Nafiseh Esmaeil · 2024 · Journal of Clinical Virology Plus
49. Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients
    Shuhei Sakakibara, Yu‐Chen Liu, Masakazu Ishikawa, Ryuya Edahiro, Yuya Shirai, Soichiro Haruna, Marwa Ali El Hussien, Zichang Xu, Songling Li, Yuta Yamaguchi et al. · 2024 · Life Science Alliance
50. FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells
    Kevin Shuolong Kao, Nicole Loren Pihlstrom, Emily G. Niejadlik, Tineke Cantaert, Rafi Ahmed, Jeffrey V. Ravetch, Stylianos Bournazos · 2025 · Proceedings of the National Academy of Sciences
51. ARDS in the time of corona: context and perspective
    Norbert Felix Voelkel, Harm Jan Bogaard, Wolfgang Michael Kuebler · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
52. Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan
    Yukie Kashima, Taketoshi Mizutani, Kaori Nakayama‐Hosoya, Saya Moriyama, Takayuki Matsumura, Yoshihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Kazuhito Miyazaki et al. · 2023 · Scientific Reports
53. RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion
    Sebastian Stricker, Niklas Ziegahn, Martin Karsten, Thomas Boeckel, Heike Stich-Boeckel, Jakob Maske, Evelyn Rugo, Anita Balázs, Pamela Millar-Büchner, Chantip Dang‐Heine et al. · 2023 · BMJ Open
54. Digitalisation Affecting Sustainability Evidence from the European Union
    Aurelija Burinskienė, Milena Medineckienė · 2022 · Preprints.org
55. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with Covid-19: an open-label randomized controlled trial
    Elisabeth De Leeuw, Karel F. A. Van Damme, Jozefien Declercq, Cédric Bosteels, Bastiaan Maes, Simon Jan Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf et al. · 2022 · Research Square
56. T cell transcriptional landscapes are shaped by TCR sequence similarity
    Hao Wang, Zhicheng Ji · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
57. Neural Network-Assisted Humanization of COVID-19 Hamster scRNAseq Data Reveals Matching Severity States in Human Disease
    Vincent D. Friedrich, Peter Pennitz, Emanuel Wyler, Julia Maria Adler, Dylan Postmus, Luiz Gustavo Teixeira Alves, Julia Prigann, Fabian Pott, Daria Vladimirova, Thomas Hoefler et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
58. BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features
    Claudia De Pasquale, Fabiana Drommi, Alessia Calabrò, Cirino Botta, Giacomo Sidoti Migliore, Paolo Carrega, Grazia Vento, Amirhossein Gaeini, Gaetana Pezzino, Josè Freni et al. · 2025 · Journal of Allergy and Clinical Immunology
59. Clinical Value of Complement C3a, C5a, and sC5b-9 in Evaluating the Severity of Patients with Severe Fever with Thrombocytopenia Syndrome
    Tianyan Chen, Yawen Liu, Yuan Liu, Nannan Hu, Yan Dai, Chuanlong Zhu, Yaping Han, Ke Jin, Jun Li · 2025 · Journal of Inflammation Research
60. High-dimensional immune profiling identifies circulating NK and T cell subpopulations associated with asymptomatic COVID-19 and absence of multiple long-term symptoms
    Johanna Bodin, Anja Bråthen Kristoffersen, Tove Karin Herstad, Gro Tunheim, Sabin Bhandari, Anna Hayman Robertson, Ratnadeep Mukherjee, Unni Cecilie Nygaard, Fredrik Oftung, Lisbeth Meyer Næss · 2025 · Clinical Immunology
61. Profiles of PCSK9, SREBP-2, and histopathology in COVID-19 and non-COVID-19 critical illness
    Florian Weber, Vlad Pavel, Martina Müller, Peter Boor, Lea Läber, Saskia Freifrau von Stillfried, Christa Buechler · 2025 · BMC Infectious Diseases
62. Myocarditis and COVID-19 related issues
    Michele Ciabatti, Chiara Zocchi, Iacopo Olivotto, Leonardo Bolognese, Maurizio Pieroni · 2023 · Global Cardiology Science and Practice
63. Impact of Diabetes on Persistent Radiological Abnormalities and Pulmonary Diffusion Dysfunction in COVID-19 Survivors: A 3-Year Prospective Cohort Study
    Linxia Wu, Xiaoyu Han, Lu Chen, Li-Yan Guo, Yumin Li, Osamah Alwalid, Tong Nie, Feihong Wu, Xiaoling Zhi, Yanqing Fan et al. · 2024 · Academic Radiology
64. RUCova: Removal of Unwanted Covariance in mass cytometry data
    Rosario Astaburuaga-García, Thomas Sell, Samet Mutlu, Anja Sieber, Kirsten Lauber, Nils Blüthgen · 2024 · Bioinformatics
65. Characteristics of peripheral lymphocyte subsets and antibodies in COVID-19-infected kidney transplantation recipients
    Honghui Long, Yunze Tai, Jiwen Fan, Xiaoqi Ou, Lin Yan, Fan Yu, Weihua Feng, Jie Chen, Yi Li · 2024 · International Immunopharmacology
66. Single-Cell RNA Sequencing (sc-RNAseq) in the Development of Biomedical Therapeutics
    Phei Er Saw, Erwei Song · 2025 · Springer eBooks
67. A predominately pulmonary activation of complement in a mouse model of severe COVID-19
    Peter J. Szachowicz, Christine Wohlford-Lenane, Cobey J. Heinen, Shreya Ghimire, Biyun Xue, Timothy J. Boly, Abhishek Verma, Leila MašinoviĆ, Jennifer Bermick, Stanley M. Perlman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
68. Soluble IL-2R contributes to impaired muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID
    Laura P. Brown, Jai Kumar Joshi, Kate Kosmac, Douglas E. Long, Ashley A. Montgomery-Yates, Anna G. Kalema, Jamie Sturgill, Hemendra J. Vekaria, Patrick Sullivan, Dylan T. Wilburn et al. · 2024 · medRxiv
69. Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn’s Disease
    Cristina Maria Chiarolla, Axel R. Schulz, Michael Meir, Simone Reu‐Hofer, Addi J. Romero‐Olmedo, Michael Lohoff, Andreas Rosenwald, Hyun-Dong Chang, Nicolas Schlegel, Henrik E. Mei et al. · 2022 · medRxiv
70. Integration of protein context improves protein- based COVID-19 patient stratification
    Jinlong Gao, Jiale He, Fangfei Zhang, Qi Xiao, Xue Cai, Xiao Yi, Siqi Zheng, Ying Zhang, Donglian Wang, Guangjun Zhu et al. · 2022 · Research Square
71. 2 Jahre COVID-19-Pandemie – was haben wir gelernt?
    Bernhard Maisch, Rolf Dörr · 2022 · Herz
72. Innate immune responses in COVID-19
    Etienne D. Jacotot, Laura Talamini, Srinivasa Reddy Bonam, Angelica Thomas Vieira, Véronique Frémeaux‐Bacchi, Marko Z. Radic, Marie‐Agnès Dragon‐Durey, José Manuel Lozano, Rafael Simone Saia, Sylviane Muller · 2023 · Elsevier eBooks
73. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
74. Immune signature of patients with cardiovascular disease – in-depth immunophenotyping predicts increased risk for a severe course of COVID-19
    Manina Günter, Karin Anne Lydia Mueller, Mathew J. Salazar, Sarah Gekeler, Carolin Prang, Tobias Harm, Meinrad Gawaz, Stella E. Autenrieth · 2023 · medRxiv
75. Reviewer #3 (Public Review): Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    2023
76. Reviewer #1 (Public Review): Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    2023
77. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2023
78. eLife Assessment: Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Shahram Y. Kordasti · 2023
79. Dual-Targeting Delivery of TPCA-1-Loaded Nanoparticles Improves the Treatment of Uncontrolled Inflammation
    Zhaozhao Chen, Lili Luo, Wenjing Luo, Lu Tang, Yingying Li, Xindi Wang, Linlin Huang, Yu Hu, Heng Mei · 2023 · SSRN Electronic Journal
80. Haunting innate immune memories of COVID-19
    Birgit Sawitzki · 2023 · Cell
81. Incorporating Translational Data into Immunosuppression Decisions During COVID-19
    Vinay V Nair, Nicholas Jandovitz, Gayatri B. Nair, Frances R. Wallach, Jeffery Lo, Ernesto P. Molmenti, Ilan Berlinrut · 2023 · Current Transplantation Reports
82. Better chance of survival is associated with higher neutrophil CD16 expression in patients with complicated intra-abdominal infections
    Evgeni Nikolaev Dimitrov, Krasimira S. Halacheva, Georgi Minkov, Emil Enchev, Yovcho P. Yovtchev · 2024 · European Journal of Microbiology and Immunology
83. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2024 · eLife
84. Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
    Daisuke Kasugai, Taku Tanaka, Takako Suzuki, Yoshinori Ito, Kazuki Nishida, Masayuki Ozaki, Takeo Kutsuna, Toshiki Yokoyama, Hitoshi Kaneko, Ryo Ogata et al. · 2024 · Frontiers in Immunology
85. Reviewer #2 (Public Review): Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    2024 · eLife
86. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto · 2024 · eLife
87. Additional file 5 of Integration of protein context improves protein-based COVID-19 patient stratification
    Jinlong Gao, Jiale He, Fangfei Zhang, Qi Xiao, Xue Cai, Yi Xiao, Siqi Zheng, Ying Zhang, Donglian Wang, Guangjun Zhu et al. · 2022 · Figshare
88. Additional file 3 of Integration of protein context improves protein-based COVID-19 patient stratification
    Jinlong Gao, Jiale He, Fangfei Zhang, Qi Xiao, Xue Cai, Yi Xiao, Siqi Zheng, Zhang, Ying, Donglian Wang, Guangjun Zhu et al. · 2022 · Figshare
89. Additional file 4 of Integration of protein context improves protein-based COVID-19 patient stratification
    Jinlong Gao, Jiale He, Fangfei Zhang, Qi Xiao, Xue Cai, Yi, Xiao, Siqi Zheng, Zhang, Ying, Donglian Wang, Guangjun Zhu et al. · 2022 · Figshare
90. Complement is Primarily Activated in the Lung in a Severe COVID-19 Mouse Model
    Peter J. Szachowicz, Christine Wohlford-Lenane, Cobey J. Heinen, Shreya Ghimire, Biyun Xue, Timothy J. Boly, Abhishek Verma, Leila MašinoviĆ, Jennifer Bermick, Stanley M. Perlman et al. · 2024 · SSRN Electronic Journal
91. Inhibition of NLRP3 oligomerization (active conformation) mediated by RACK1 ameliorates acute respiratory distress syndrome
    Yinan Zhang, Jian Cui, Meng Yang, Chengli Yu, Haidong Zhang, Yuan Gong, Yang Hu, Yue Wang, Qingxin Yuan, An Pan et al. · 2024 · Research Square
92. Randomized Phase 2 Trial of Lirilumab as maintenance Treatment in Acute Myeloid Leukemia: Results of the EFFIKIR Trial
    Norbert Vey, Anne-Sophie Chrétien, Pierre Yves Dumas, Christian Récher, Lauris Gastaud, Bruno Lioure, Claude‐Eric Bulabois, Cécile Pautas, JP Marolleau, Stéphane Leprêtre et al. · 2024 · medRxiv
93. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
    Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, Philipp Georg, David Hillus, Anna Luisa Hiller, Rosario Astaburuaga-García, Nils Blüthgen, Emanuel Wyler, Katrin Vogt et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
94. Immune status in women after COVID-19 living in the subarctic region
    Lyubov’ S. Shchegoleva, Elizaveta Yu. Shashkova, Mohammad S. Kabbani, Филиппова Оксана Евгеньевна · 2024 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
95. Immunophenotyping of T Cells in Lung Malignancies and Cryptogenic Organizing Pneumonia
    Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshinori Fukui, Isamu Okamoto · 2025 · Journal of Clinical Medicine
96. Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection
    Yuqi Zhang, Xinjie Li, Yingxiang Yang, Yue Yin, Yan Zhong, Qiang Xu, Jing Tu, Juan Deng, Hua Liang, Tao Shen · 2025 · Vaccine
97. Increased fatty acid production and macrophage‐driven inflammation as key drivers of severe respiratory disease
    Emily Marie Eriksson, Ivo Müeller · 2025 · Immunology and Cell Biology
98. Secretory IgA binding to FCRL3 triggers shared inflammatory cytokine secretion by human regulatory T cells and effector T cells
    Zachary Kraus, Shama V. Birla, Taylor Powell, Svetlana N. Petrovskaya, Frederick Mills, Jessica Dement-Brown, Casey Culhane, Kimia Dokhaee, Máté Tolnay · 2025 · Journal of Leukocyte Biology
99. Proteomic and Phosphoproteomic Profiling of Kidney in Rhesus Macaques With SARS‐CoV‐2 Infection
    Yizhuo Tian, Yanan Zhou, Qiaochu Wang, Xiaolu Li, Tao Ding, Yue Wu, Xiaoyue Tang, Yehong Yang, Jiangfeng Liu, Sen Lu et al. · 2025 · Journal of Medical Virology
100. Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis
     Franca Sophie Deicher, Tarik Exner, Maren Claus, Schayan Yousefian, Lea Rodon, Steven Leonhardt, Jörg H. W. Distler, Carsten Watzl, Hanns‐Martin Lorenz, Simon F. Haas et al. · 2025 · Journal of Innate Immunity